WEST PHARMACEUTICAL SERVICES, INC. Stock-Based Compensation
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Stock-Based Compensation of $17.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $10.90M, a 47.30% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $6.60M, a 407.69% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $6.70M, a 55.81% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $8.40M, a 64.71% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $23.80M, a 27.27% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $18.70M, a 19.74% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $23.30M, a 1.69% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $23.70M, a 36.80% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $17.50M 10-Q · filed 2026-07-23 | $24.20M derived: sum of 3 quarters · filed 2026-07-23 | $32.60M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $6.60M 10-Q · filed 2026-04-23 | $13.30M derived: sum of 2 quarters · filed 2026-04-23 | $21.70M derived: sum of 3 quarters · filed 2026-04-23 | $29.10M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $15.10M derived: sum of 2 quarters · filed 2026-02-17 | $22.50M derived: sum of 3 quarters · filed 2026-07-23 | $23.80M 10-K · filed 2026-02-17 |
| 2025-09-30 | $8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $15.80M derived: sum of 2 quarters · filed 2026-07-23 | $17.10M 10-Q · filed 2025-10-23 | $21.40M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $8.70M 10-Q · filed 2026-07-23 | $13.00M derived: sum of 3 quarters · filed 2026-07-23 | $18.10M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $1.30M 10-Q · filed 2026-04-23 | $5.60M derived: sum of 2 quarters · filed 2026-04-23 | $10.70M derived: sum of 3 quarters · filed 2026-04-23 | $15.00M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $9.40M derived: sum of 2 quarters · filed 2026-02-17 | $13.70M derived: sum of 3 quarters · filed 2026-02-17 | $18.70M 10-K · filed 2026-02-17 |
| 2024-09-30 | $5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $9.40M derived: sum of 2 quarters · filed 2025-10-23 | $14.40M 10-Q · filed 2025-10-23 | $15.80M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $9.30M 10-Q · filed 2025-07-24 | $10.70M derived: sum of 3 quarters · filed 2026-02-17 | $16.60M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $5.00M 10-Q · filed 2025-04-24 | $6.40M derived: sum of 2 quarters · filed 2026-02-17 | $12.30M derived: sum of 3 quarters · filed 2026-02-17 | $19.80M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $7.30M derived: sum of 2 quarters · filed 2026-02-17 | $14.80M derived: sum of 3 quarters · filed 2026-02-17 | $23.30M 10-K · filed 2026-02-17 |
| 2023-09-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $13.40M derived: sum of 2 quarters · filed 2024-10-24 | $21.90M 10-Q · filed 2024-10-24 | $28.60M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $16.00M 10-Q · filed 2024-07-25 | $22.70M derived: sum of 3 quarters · filed 2025-02-18 | $28.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $8.50M 10-Q · filed 2024-04-25 | $15.20M derived: sum of 2 quarters · filed 2025-02-18 | $21.20M derived: sum of 3 quarters · filed 2025-02-18 | $26.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $12.70M derived: sum of 2 quarters · filed 2025-02-18 | $18.20M derived: sum of 3 quarters · filed 2025-02-18 | $23.70M 10-K · filed 2025-02-18 |
| 2022-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $11.50M derived: sum of 2 quarters · filed 2023-10-26 | $17.00M 10-Q · filed 2023-10-26 | $27.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $11.00M 10-Q · filed 2023-07-27 | $21.00M derived: sum of 3 quarters · filed 2024-02-20 | $32.30M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $5.50M 10-Q · filed 2023-04-27 | $15.50M derived: sum of 2 quarters · filed 2024-02-20 | $26.80M derived: sum of 3 quarters · filed 2024-02-20 | $37.10M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $21.30M derived: sum of 2 quarters · filed 2024-02-20 | $31.60M derived: sum of 3 quarters · filed 2024-02-20 | $37.50M 10-K · filed 2024-02-20 |
| 2021-09-30 | $11.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $21.60M derived: sum of 2 quarters · filed 2022-10-27 | $27.50M 10-Q · filed 2022-10-27 | $33.90M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $16.20M 10-Q · filed 2022-07-28 | $22.60M derived: sum of 3 quarters · filed 2023-02-21 | $32.50M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $5.90M 10-Q · filed 2022-04-28 | $12.30M derived: sum of 2 quarters · filed 2023-02-21 | $22.20M derived: sum of 3 quarters · filed 2023-02-21 | $34.50M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $16.30M derived: sum of 2 quarters · filed 2023-02-21 | $28.60M derived: sum of 3 quarters · filed 2023-02-21 | $34.00M 10-K · filed 2023-02-21 |
| 2020-09-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $22.20M derived: sum of 2 quarters · filed 2021-10-28 | $27.60M 10-Q · filed 2021-10-28 | $33.20M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $12.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $17.70M 10-Q · filed 2021-07-30 | $23.30M derived: sum of 3 quarters · filed 2022-02-22 | $28.70M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $5.40M 10-Q · filed 2021-04-30 | $11.00M derived: sum of 2 quarters · filed 2022-02-22 | $16.40M derived: sum of 3 quarters · filed 2022-02-22 | $23.60M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $11.00M derived: sum of 2 quarters · filed 2022-02-22 | $18.20M derived: sum of 3 quarters · filed 2022-02-22 | $24.40M 10-K · filed 2022-02-22 |
| 2019-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $12.60M derived: sum of 2 quarters · filed 2020-10-23 | $18.80M 10-Q · filed 2020-10-23 | $19.20M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $13.40M 10-Q · filed 2020-07-24 | $13.80M derived: sum of 3 quarters · filed 2021-02-23 | $19.10M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $6.20M 10-Q · filed 2020-04-24 | $6.60M derived: sum of 2 quarters · filed 2021-02-23 | $11.90M derived: sum of 3 quarters · filed 2021-02-23 | $17.90M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $5.70M derived: sum of 2 quarters · filed 2021-02-23 | $11.70M derived: sum of 3 quarters · filed 2021-02-23 | $15.10M 10-K · filed 2021-02-23 |
| 2018-09-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $11.30M derived: sum of 2 quarters · filed 2019-10-29 | $14.70M 10-Q · filed 2019-10-29 | $17.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $9.40M 10-Q · filed 2019-07-29 | $11.90M derived: sum of 3 quarters · filed 2020-02-24 | $16.50M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $3.40M 10-Q · filed 2019-05-08 | $5.90M derived: sum of 2 quarters · filed 2020-02-24 | $10.50M derived: sum of 3 quarters · filed 2020-02-24 | $16.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $7.10M derived: sum of 2 quarters · filed 2020-02-24 | $12.60M derived: sum of 3 quarters · filed 2020-02-24 | $16.10M 10-K · filed 2020-02-24 |
| 2017-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $10.10M derived: sum of 2 quarters · filed 2018-10-30 | $13.60M 10-Q · filed 2018-10-30 | $19.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $9.00M 10-Q · filed 2018-07-31 | $14.40M derived: sum of 3 quarters · filed 2019-02-28 | $19.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $3.50M 10-Q · filed 2018-05-08 | $8.90M derived: sum of 2 quarters · filed 2019-02-28 | $13.50M derived: sum of 3 quarters · filed 2019-02-28 | $18.40M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $10.00M derived: sum of 2 quarters · filed 2019-02-28 | $14.90M derived: sum of 3 quarters · filed 2019-02-28 | $19.50M 10-K · filed 2019-02-28 |
| 2016-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $9.50M derived: sum of 2 quarters · filed 2017-10-31 | $14.10M 10-Q · filed 2017-10-31 | $19.30M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $9.50M 10-Q · filed 2017-08-01 | $14.70M derived: sum of 3 quarters · filed 2018-02-26 | $18.30M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $4.60M 10-Q · filed 2017-05-05 | $9.80M derived: sum of 2 quarters · filed 2018-02-26 | $13.40M derived: sum of 3 quarters · filed 2018-02-26 | $28.90M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $8.80M derived: sum of 2 quarters · filed 2018-02-26 | $24.30M derived: sum of 3 quarters · filed 2018-02-26 | $29.60M 10-K · filed 2018-02-26 |
| 2015-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $19.10M derived: sum of 2 quarters · filed 2016-10-31 | $24.40M 10-Q · filed 2016-10-31 | $30.50M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $15.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $20.80M 10-Q · filed 2016-08-01 | $26.90M derived: sum of 3 quarters · filed 2017-02-28 | $30.50M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $5.30M 10-Q · filed 2016-05-06 | $11.40M derived: sum of 2 quarters · filed 2017-02-28 | $15.00M derived: sum of 3 quarters · filed 2017-02-28 | $19.60M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $9.70M derived: sum of 2 quarters · filed 2017-02-28 | $14.30M derived: sum of 3 quarters · filed 2017-02-28 | $18.60M 10-K · filed 2017-02-28 |
| 2014-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $8.20M derived: sum of 2 quarters · filed 2015-11-02 | $12.50M 10-Q · filed 2015-11-02 | $18.10M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $8.90M 10-Q · filed 2015-08-03 | $14.50M derived: sum of 3 quarters · filed 2016-02-26 | $19.70M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $4.30M 10-Q · filed 2015-05-06 | $9.90M derived: sum of 2 quarters · filed 2016-02-26 | $15.10M derived: sum of 3 quarters · filed 2016-02-26 | $20.10M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $10.80M derived: sum of 2 quarters · filed 2016-02-26 | $15.80M derived: sum of 3 quarters · filed 2016-02-26 | $21.20M 10-K · filed 2016-02-26 |
| 2013-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $10.20M derived: sum of 2 quarters · filed 2014-11-03 | $15.60M 10-Q · filed 2014-11-03 | $19.30M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $10.40M 10-Q · filed 2014-08-01 | $14.10M derived: sum of 3 quarters · filed 2015-02-25 | |
| 2013-03-31 | $5.40M 10-Q · filed 2014-05-08 | $9.10M derived: sum of 2 quarters · filed 2015-02-25 | ||
| 2012-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $15.50M 10-K · filed 2015-02-25 | ||
| 2012-09-30 | $11.80M 10-Q · filed 2013-11-04 | |||
| 2011-12-31 | $8.40M 10-K · filed 2014-02-27 | |||
| 2010-12-31 | $7.80M 10-K · filed 2013-02-27 | |||
| 2009-12-31 | $7.50M 10-K/A · filed 2012-03-01 | |||
| 2008-12-31 | $6.40M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |